Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather M O'Leary

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Neurodevelopmental Disorders|September 18, 2015
Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scalesKatherine V Barnes, Francesca R Coughlin, Heather M O'Leary, et al.
Pediatric Neurology|March 25, 2015
Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosisDaniel C Tarquinio, Wei Hou, Jeffrey L Neul, et al.
Orphanet Journal of Rare Diseases|August 13, 2024
Burden of illness in Rett syndrome: initial evaluation of a disorder-specific caregiver surveyWalter E Kaufmann, Alan K Percy, Jeffrey L Neul, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndromeHeather M O'Leary, Walter E Kaufmann, Katherine V Barnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2014
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndromeOmar S Khwaja, Eugenia Ho, Katherine V Barnes, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Neurodevelopmental Disorders|September 18, 2015
Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scalesKatherine V Barnes, Francesca R Coughlin, Heather M O'Leary, et al.
Pediatric Neurology|March 25, 2015
Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosisDaniel C Tarquinio, Wei Hou, Jeffrey L Neul, et al.
Orphanet Journal of Rare Diseases|August 13, 2024
Burden of illness in Rett syndrome: initial evaluation of a disorder-specific caregiver surveyWalter E Kaufmann, Alan K Percy, Jeffrey L Neul, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndromeHeather M O'Leary, Walter E Kaufmann, Katherine V Barnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2014
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndromeOmar S Khwaja, Eugenia Ho, Katherine V Barnes, et al.
Pageof 2